Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Cell Communication and Signaling : CCS|November 23, 2019
Distinct functions of AKT isoforms in breast cancer: a comprehensive reviewNico Hinz, Manfred JückerInternational Journal of Molecular Sciences|July 29, 2025
The Role of PI3K/AKT/mTOR Signaling in Tumor Radioresistance and Advances in Inhibitor ResearchJian Zhan, Manfred JückerCancers|January 11, 2022
The Functional Role of Extracellular Matrix Proteins in CancerNadezhda V Popova, Manfred JückerBiochemical Pharmacology|December 1, 2019
PI3K/AKT/mTOR signaling as a molecular target in head and neck cancerFranziska E Marquard, Manfred JückerInternational Journal of Molecular Sciences|May 25, 2024
The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human DiseasesSpike Murphy Müller, Manfred JückerCurrent Topics in Microbiology and Immunology|October 15, 2022
AKT Isoforms as a Target in Cancer and ImmunotherapyDaniel J Smit, Manfred JückerInternational Journal of Molecular Sciences|February 12, 2021
The Role of mTOR Signaling as a Therapeutic Target in CancerNadezhda V Popova, Manfred JückerCellular Signalling|June 28, 2012
Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domainBianca T Hofmann, Manfred JückerAnticancer Research|May 6, 2021
Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug ScreeningDominik Nörz, Christina S Mullins, Daniel J Smit, et al.Biochemical Pharmacology|May 1, 2021
Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapyDaniel J Smit, Klaus Pantel, Manfred JückerPageof 8